Hope for ALS: new drug enters final testing phase
Disease control
Recruiting now
This study tests whether the drug pridopidine can slow the progression of ALS, a serious nerve disease. About 500 adults with early-stage ALS will take either pridopidine or a placebo daily for 48 weeks, then all will receive pridopidine for another 48 weeks. Researchers will mea…
Phase: PHASE3 • Sponsor: Prilenia • Aim: Disease control
Last updated May 26, 2026 11:16 UTC